{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T02:06:44Z","timestamp":1793066804407,"version":"4.5.0"},"reference-count":25,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","clinical-lung-cancer.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Lung Cancer"],"published-print":{"date-parts":[[2025,3]]},"DOI":"10.1016\/j.cllc.2024.10.016","type":"journal-article","created":{"date-parts":[[2024,11,14]],"date-time":"2024-11-14T11:33:24Z","timestamp":1731584004000},"page":"116-123","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Association of Oncogene Driver Mutations with Recurrence and Survival in Stage I Nonsmall Cell Lung Cancer"],"prefix":"10.1016","volume":"26","author":[{"given":"Daniel M.","family":"Libby","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-1490-8636","authenticated-orcid":false,"given":"Laura J.","family":"Libby","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoyue","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jason","family":"Chua","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tahj","family":"Blow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peyman","family":"Razavi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashish","family":"Saxena","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cllc.2024.10.016_bib0001","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.jtho.2015.09.009","article-title":"The IASLC Lung Cancer Staging Project: proposals for revision of the TNM stage groupings in the forthcoming (eighth) edition of the TNM classification for lung cancer","volume":"11","author":"Goldstraw","year":"2016","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.cllc.2024.10.016_bib0002","doi-asserted-by":"crossref","first-page":"117","DOI":"10.3949\/ccjm.88a.19148","article-title":"Precision treatment for metastatic non-small cell lung cancer: a conceptual overview","volume":"88","author":"Lee","year":"2021","journal-title":"Cleve Clin J Med"},{"key":"10.1016\/j.cllc.2024.10.016_bib0003","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1038\/s41571-018-0002-6","article-title":"The emerging clinical relevance of genomics in cancer medicine","volume":"15","author":"Berger","year":"2018","journal-title":"Nat Rev\/Clin Oncol"},{"key":"10.1016\/j.cllc.2024.10.016_bib0004","doi-asserted-by":"crossref","first-page":"2817","DOI":"10.1056\/NEJMoa041588","article-title":"A multigene assay to predict recurrence of tamoxifen-treated, node-negative breast cancer","volume":"351","author":"Paik","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cllc.2024.10.016_bib0005","doi-asserted-by":"crossref","first-page":"6538","DOI":"10.1002\/cam4.2415","article-title":"Genomic stratification beyond Ras\/B-Raf in colorectal liver metastasis patients treated with hepatic arterial infusion","volume":"8","author":"Smith","year":"2019","journal-title":"Cancer Med"},{"key":"10.1016\/j.cllc.2024.10.016_bib0006","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1056\/NEJMoa1611604","article-title":"Prognostic mutations in myelodysplastic syndrome after stem-cell transplantation","volume":"376","author":"Lindsley","year":"2017","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cllc.2024.10.016_bib0007","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.pathol.2016.08.016","article-title":"Clinical validation of the 50 gene AmpliSeq Cancer Panel V2 for use on a next generation sequencing platform using formalin fixed, paraffin embedded and fine needle aspiration tumor specimens","volume":"49","author":"Rathi","year":"2017","journal-title":"Pathology"},{"key":"10.1016\/j.cllc.2024.10.016_bib0008","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1002\/cncy.22270","article-title":"Preanalytic variables in quality and quantity of nucleic acids extracted from FNA specimens of thyroid gland nodules collected in CytoLyt: cellularity and storage time","volume":"128","author":"Heymann","year":"2020","journal-title":"Cancer Cytopathol"},{"key":"10.1016\/j.cllc.2024.10.016_bib0009","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.jmoldx.2016.10.002","article-title":"Standards and guidelines for the interpretation and reporting of sequence variants in cancer: a joint consensus recommendation of the association for molecular pathology, American society of clinical oncology and college of American pathologists","volume":"19","author":"Li","year":"2017","journal-title":"J Mol Diagn"},{"key":"10.1016\/j.cllc.2024.10.016_bib0010","doi-asserted-by":"crossref","first-page":"1787","DOI":"10.1016\/S1470-2045(21)00580-5","article-title":"Cancer incidence, patterns, and genotype-phenotype associations in individuals with pathogenic or likely pathogenic germline TP53 variants: an observational cohort study","volume":"22","author":"De Andrade","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/j.cllc.2024.10.016_bib0011","doi-asserted-by":"crossref","first-page":"1746","DOI":"10.1093\/annonc\/mdw261","article-title":"Outcome according to KRAS-, NRAS- and BRAF-mutation as well as KRAS mutation variants: pooled analysis of five randomized trials in metastatic colorectal cancer by the AIO colorectal cancer study group","volume":"27","author":"Modest","year":"2016","journal-title":"Ann Oncol"},{"key":"10.1016\/j.cllc.2024.10.016_bib0012","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1016\/j.jtho.2018.12.013","article-title":"K-ras mutation subtypes in NSCLC and associated Co-occurring mutations in other oncogenic pathways","volume":"14","author":"Scheffler","year":"2018","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.cllc.2024.10.016_bib0013","doi-asserted-by":"crossref","first-page":"2018","DOI":"10.1200\/JCO.2016.71.2893","article-title":"Pooled analysis of the prognostic and predictive effects of TP53 commutation status combined with KRAS or EGFR mutation in early-stage resected non-small-cell lung cancer in four trials of adjuvant chemotherapy","volume":"35","author":"Shepherd","year":"2017","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.cllc.2024.10.016_bib0014","doi-asserted-by":"crossref","first-page":"2173","DOI":"10.1200\/JCO.2012.48.1390","article-title":"Pooled analysis of the prognostic and predictive effects of the KRAS mutation status and KRAS mutation subtype in early stage resected non-small-cell lung cancer in four trials of adjuvant chemotherapy","volume":"31","author":"Shepherd","year":"2013","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.cllc.2024.10.016_bib0015","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1016\/S2213-2600(23)00041-3","article-title":"Segmentectomy for ground-glass-dominant lung cancer with a tumor diameter of 3 cm or less including ground glass opacity (JCOG121)","volume":"11","author":"Aokaage","year":"2023","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.cllc.2024.10.016_bib0016","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.athoracsur.2020.05.041","article-title":"Clinical Impacts of EGFR mutation status: analysis of 5780 surgically resected lung cancer cases","volume":"111","author":"Suda","year":"2021","journal-title":"Ann Thorac Surg"},{"key":"10.1016\/j.cllc.2024.10.016_bib0017","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.lungcan.2019.06.026","article-title":"The incidence of Lymph node metastasis in patients with different oncogenic driver mutations among T1 non-small-cell lung cancer","volume":"134","author":"Liu","year":"2019","journal-title":"Lung Cancer"},{"key":"10.1016\/j.cllc.2024.10.016_bib0018","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.1056\/NEJMoa2027071","article-title":"Osimertinib in resected EGFR-mutated non-small cell lung cancer","volume":"383","author":"Wu","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cllc.2024.10.016_bib0019","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1016\/j.cllc.2023.02.002","article-title":"Adjuvant Osimertinib vs Placebo in completely resected stage IA2-IA3 EGFR-mutated NSCLC: ADAURA2","volume":"24","author":"Tsutani","year":"2023","journal-title":"Clin Lung Cancer"},{"key":"10.1016\/j.cllc.2024.10.016_bib0020","first-page":"585","article-title":"Alectinib in resected ALK-positive non-small cell lung cancer","volume":"391","author":"Wu","year":"2024","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cllc.2024.10.016_bib0021","doi-asserted-by":"crossref","first-page":"512","DOI":"10.7326\/0003-4819-106-4-512","article-title":"Airways obstruction and the risk for lung cancer","volume":"106","author":"Tockman","year":"1987","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.cllc.2024.10.016_bib0022","doi-asserted-by":"crossref","first-page":"1932","DOI":"10.1378\/chest.07-1490","article-title":"Assessing the relationship between lung cancer risk and emphysema detected on low-dose CT of the chest","volume":"132","author":"de Torres","year":"2007","journal-title":"Chest"},{"key":"10.1016\/j.cllc.2024.10.016_bib0023","first-page":"1963","article-title":"Survival of patients with clinical stage I lung cancer detected with computed tomography","volume":"355","author":"Henschke","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cllc.2024.10.016_bib0024","doi-asserted-by":"crossref","first-page":"1980","DOI":"10.1056\/NEJMoa1209120","article-title":"Results of initial low-dose computed tomographic screening for lung cancer","volume":"368","year":"2013","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cllc.2024.10.016_bib0025","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1056\/NEJMoa1911793","article-title":"Reduced lung-cancer mortality with volume CT screening in a randomized trial","volume":"382","author":"De Koning","year":"2020","journal-title":"N Engl J Med"}],"container-title":["Clinical Lung Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S152573042400233X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S152573042400233X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,2,8]],"date-time":"2025-02-08T12:34:33Z","timestamp":1739018073000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S152573042400233X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3]]},"references-count":25,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025,3]]}},"alternative-id":["S152573042400233X"],"URL":"https:\/\/doi.org\/10.1016\/j.cllc.2024.10.016","relation":{},"ISSN":["1525-7304"],"issn-type":[{"value":"1525-7304","type":"print"}],"subject":[],"published":{"date-parts":[[2025,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Association of Oncogene Driver Mutations with Recurrence and Survival in Stage I Nonsmall Cell Lung Cancer","name":"articletitle","label":"Article Title"},{"value":"Clinical Lung Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cllc.2024.10.016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}